EP Patent

EP1905424A3 — Process for the preparation of a pharmaceutical composition comprising stabilized statin particles

Assigned to Ranbaxy Laboratories Ltd · Expires 2008-04-30 · 18y expired

What this patent protects

The present invention relates to a process for preparation of stabilized statin particles, whereby one or mor stabilizers are dissolved/dispersed in a solvent and whereby the solution/dispersion of stabilizers is sprayed onto the amorphous statin, in particular atorvastatin.

USPTO Abstract

The present invention relates to a process for preparation of stabilized statin particles, whereby one or mor stabilizers are dissolved/dispersed in a solvent and whereby the solution/dispersion of stabilizers is sprayed onto the amorphous statin, in particular atorvastatin.

Drugs covered by this patent

Patent Metadata

Patent number
EP1905424A3
Jurisdiction
EP
Classification
Expires
2008-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Ranbaxy Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.